Nasal High Flow Therapy May Reduce Sympathetic Drive in Pulmonary Hypertension and OSA
Nighttime nasal high flow therapy at 20 L/min reduced sympathetic drive in patients with precapillary pulmonary hypertension and obstructive sleep apnea.
Obstructive Sleep Apnea
CPAP Therapy for 6 Months in OSA May Reverse Metabolic Syndrome
Continuous positive airway pressure therapy for 6 months offers patients with obstructive sleep apnea a greater chance of reversing metabolic syndrome.
Obstructive Sleep Apnea Burden Improvement With vs Without Upper Airway Stimulation
The burden of both objective and subjective obstructive sleep apnea improved more in patients who received upper airway stimulation compared with those who did not.
CPAP Adherence in Low Cardiovascular Risk OSA Not Improved With Telemonitoring
Use of a multimodal telemonitoring intervention in patients with severe OSA and low cardiovascular risk does not increase adherence to CPAP treatment.
Pitolisant Add-On CPAP Therapy Reduces Excessive Daytime Sleepiness in OSA
Pitolisant may be used as an add-on therapy to continuous positive airway pressure in patients with obstructive sleep apnea suffering from residual diurnal somnolence.
Inspire Therapy Approved for Younger Patients With Obstructive Sleep Apnea
The FDA has expanded the approval of Inspire therapy to include patients aged 18 to 21 years with moderate to severe OSA who are unable to use CPAP.
Convolution Neural Network Deep Learning Model Predicts Sleep Disorder in Asthma
Of the various deep learning approaches tested, the convolution neural network model showed the best ability to predict sleep disorder in a cohort of individuals with asthma.
Physiologic Traits Associated CPAP Adherence in Patients With Stroke and OSA
Physiologic traits that cause obstructive sleep apnea are also associated with adherence to continuous positive airway pressure in patients with stroke.
SNORE Utility Index Validated as Novel Sleep Apnea-Specific QoL Instrument
Researchers have developed and validated the SNORE (Symptoms of Nocturnal Obstruction and Related Events) Utility Index, a novel utility scoring algorithm, for use as a sleep apnea-specific quality-of-life instrument.
Atomoxetine Plus Oxybutynin Improves Multiple Variables in Obstructive Sleep Apnea
Atomoxetine plus oxybutynin demonstrated efficacy in improving upper airway collapsibility, increasing breathing stability, and reducing the threshold for arousal in obstructive sleep apnea.
-
Loading...
-
Loading...
Next post in Obstructive Sleep Apnea-OSA
